Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone metastases: pathophysiology and management policy.

O S Nielsen1, A J Munro, I F Tannock

  • 1Department of Oncology, Aarhus Kommunehospital, Denmark.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.

British journal of cancer·2024
Same author

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Rules for the conduct of clinical trials need revision, but 'good clinical practice' requires much more.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Improving access to immunotherapy in low- and middle-income countries.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Have investigators forgotten how to write?

Annals of oncology : official journal of the European Society for Medical Oncology·2021

This review covers bone metastases management, focusing on palliative care to relieve pain and prevent fractures. It highlights the need for better treatment criteria and more clinical trials for cancer patients.

Area of Science:

  • Oncology
  • Bone Metastasis Management
  • Cancer Palliative Care

Background:

  • Bone metastases are common in advanced cancer, often appearing early.
  • Primary tumors typically originate in the breast, prostate, or lungs.
  • While often fatal, some patients live for years with bone metastases.

Purpose of the Study:

  • To review the pathophysiology and management of bone metastases.
  • To discuss criteria for assessing treatment response.
  • To identify needs for future clinical research.

Main Methods:

  • Literature review of pathophysiology, management options, and response criteria.
  • Analysis of palliative treatment strategies.
  • Identification of research gaps.

Related Experiment Videos

Main Results:

  • Bone metastases management is primarily palliative, aiming to improve quality of life.
  • Therapeutic options include local (radiotherapy, surgery) and systemic treatments (chemotherapy, endocrine therapy, radioisotopes, diphosphonates, analgesics).
  • Mechanisms of pain relief are not fully understood, suggesting non-tumoricidal effects are important.

Conclusions:

  • Current therapeutic options for bone metastases are diverse but lack robust comparative trials.
  • Established criteria for assessing treatment response are poorly defined.
  • Rigorous clinical investigations with validated response criteria are essential to evaluate efficacy.